SE369307B - - Google Patents

Info

Publication number
SE369307B
SE369307B SE1585567A SE1585567A SE369307B SE 369307 B SE369307 B SE 369307B SE 1585567 A SE1585567 A SE 1585567A SE 1585567 A SE1585567 A SE 1585567A SE 369307 B SE369307 B SE 369307B
Authority
SE
Sweden
Application number
SE1585567A
Inventor
K Brown
J Cavalla
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of SE369307B publication Critical patent/SE369307B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02Holding devices, e.g. on the body
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE1585567A 1966-11-18 1967-11-17 SE369307B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14

Publications (1)

Publication Number Publication Date
SE369307B true SE369307B (en) 1974-08-19

Family

ID=27516268

Family Applications (2)

Application Number Title Priority Date Filing Date
SE1585567A SE369307B (en) 1966-11-18 1967-11-17
SE7316107A SE422209B (en) 1966-11-18 1973-11-28 INTERMEDIATE FOR USE FOR THE PREPARATION OF NEW 1.3-O X 20L AND 1,3-THIAZOLD DERIVATIVES

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7316107A SE422209B (en) 1966-11-18 1973-11-28 INTERMEDIATE FOR USE FOR THE PREPARATION OF NEW 1.3-O X 20L AND 1,3-THIAZOLD DERIVATIVES

Country Status (12)

Country Link
JP (1) JPS4938267B1 (en)
BE (1) BE706625A (en)
CH (9) CH545309A (en)
DE (2) DE1670005C2 (en)
ES (1) ES347319A1 (en)
FI (1) FI50416C (en)
FR (2) FR8018M (en)
IL (1) IL28803A (en)
LU (1) LU54891A1 (en)
NL (1) NL157012B (en)
PL (1) PL72562B1 (en)
SE (2) SE369307B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (en) * 1974-07-18 1976-01-30
JPS5182675A (en) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
GB1543154A (en) * 1975-05-02 1979-03-28 Lilly Industries Ltd Urea and carbamate derivatives
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (en) * 1986-01-03 1989-03-10 Therapicon Srl WATER SOLUBLE ACID DERIVATIVES 4,5 -DIPHENYL-2 -XSAZOLPROPIONIC, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS
TW311136B (en) 1990-11-30 1997-07-21 Otsuka Pharma Co Ltd
EP0772606A1 (en) * 1994-07-27 1997-05-14 G.D. SEARLE & CO. Substituted thiazoles for the treatment of inflammation
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (en) * 1965-10-07

Also Published As

Publication number Publication date
CH545310A (en) 1973-12-15
CH545309A (en) 1973-12-15
CH556351A (en) 1974-11-29
NL157012B (en) 1978-06-15
DE1670005A1 (en) 1970-08-06
ES347319A1 (en) 1969-05-16
SE422209B (en) 1982-02-22
JPS4938267B1 (en) 1974-10-16
FI50416C (en) 1976-03-10
FI50416B (en) 1975-12-01
BE706625A (en) 1968-05-16
CH528531A (en) 1972-09-30
LU54891A1 (en) 1968-02-08
DE1670005C2 (en) 1982-06-09
PL72562B1 (en) 1974-08-30
FR1584222A (en) 1969-12-19
DE1795822C2 (en) 1982-07-15
CH560203A5 (en) 1975-03-27
CH560205A5 (en) 1975-03-27
CH536311A (en) 1973-04-30
FR8018M (en) 1970-08-03
IL28803A (en) 1974-05-16
CH554884A (en) 1974-10-15
NL6715532A (en) 1968-05-20
CH545308A (en) 1973-12-15

Similar Documents

Publication Publication Date Title
FR8018M (en)
AT281852B (en)
AU1534566A (en)
AU1141566A (en)
AU417216B2 (en)
AU415165B1 (en)
AU421822B2 (en)
AU218666A (en)
AU1111066A (en)
AU1144366A (en)
BE673316A (en)
BE626310A (en)
BE637138A (en)
AU2390066A (en)
BE694624A (en)
BE675084A (en)
BE694199A (en)
AU1027866A (en)
AU407778B2 (en)
BE693323A (en)
BE692749A (en)
BE624001A (en)
BE624223A (en)
BE597652A (en)
BE674713A (en)